FDA Will Publicize EUA Data, Information As GAO Calls For Transparency

By Beth Wang / November 17, 2020 at 5:14 PM
FDA will publicly post its reviews of data and information supporting emergency use authorization decisions for drugs and biologics, including vaccines, as part of the agency’s COVID-19 response, FDA chief Stephen Hahn announced Tuesday (Nov. 17), just a few hours before the Government Accountability Office issued a report calling for FDA to be more transparent about its sometimes inconsistent EUA reviews and decisions. A spokesperson for GAO told Inside Health Policy that FDA’s announcement seems to align with the...

Not a subscriber? Sign up for 30 days free access to exclusive, detailed reporting on drug pricing reforms, Medicaid policy, FDA news and much more.